Snehaa Organics
August 29, 2025 – September 2, 2025
| Price | ₹115 - ₹122 |
| GMP Rumors * | ₹2 |
|---|---|
| Lot size | 1000 |
| Allotment | Sep 3, 2025 |
| Listing | Sep 5, 2025 |
Live Rate
| Open | |
|---|---|
| High | |
| Low | |
| Prev. Close | |
| Lower circuit | |
| Upper circuit | |
| 52w High | |
| 52w Low | |
| P/E Ratio |
Snehaa Organics Listing Price
| Exchange | Listing Price | Gain/Loss | % |
|---|---|---|---|
| NSE | ₹122.00 | ₹0.00 | 0.00% |
Snehaa Organics Subscription
Last updated on 02-Sep-2025 18:30:04
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 126000 | 5316000 | 42.19 |
| HNIs | 1209000 | 19626000 | 16.23 |
| bHNI | 806000 | 13537000 | 16.8 |
| sHNI | 403000 | 6089000 | 15.11 |
| Individual | 1210000 | 45700000 | 37.77 |
| Total | 2545000 | 70642000 | 27.76 |
Application-Wise Breakup  | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 269 | 1419 | 5.28 |
| HNIs (3-10L) | 134 | 1817 | 13.56 |
| Individual | 605 | 22850 | 37.77 |
| Subscription Demand (in ₹ crore) | |||
|---|---|---|---|
| Category | Offered | Demand | Times |
| QIB | 1.54 | 64.86 | 42.19 |
| FII | - | 38.54 | - |
| FI | - | 0 | - |
| IC | - | 0 | - |
| MF | - | 0 | - |
| OTH | - | 26.32 | - |
| HNIs | 14.75 | 239.44 | 16.23 |
| bHNI | 9.83 | 165.15 | 16.8 |
| sHNI | 4.92 | 74.29 | 15.11 |
| Individual | 14.76 | 557.54 | 37.77 |
| Total | 31.05 | 861.83 | 27.76 |
| QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹6.9 | @8% ₹7.9 | @9% ₹8.9 | @10% ₹9.9 | @11% ₹10.9 | @12% ₹11.8 |
Snehaa Organics Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| bHNI | 9 | 9000 | 1098000 | 269 |
Snehaa Organics Reservation
| Category | Shares Offered | % |
|---|---|---|
| QIB | 126000 | 4.7% |
| HNI | 1209000 | 45.13% |
| INDIVIDUAL | 1210000 | 45.17% |
| Market Maker | 134000 | 5% |
| Total | 2679000 | 100% |
Snehaa Organics About
IPO Details
| Issue size | 26,79,000 shares (aggregating up to ₹32.68 Cr) |
| Fresh Issue | 26,79,000 shares (aggregating up to ₹32.68 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 75,00,000 shares |
| Share Holding Post Issue | 1,01,79,000 shares |
| Reserved for Market Maker | 1,34,000 shares (aggregating up to ₹1.63 Cr) |
| Market Maker | Nirman Share Brokers Pvt.Ltd. |
Key Performance Indicator (KPI)
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 49.46% | 49.20% | 73.53% |
| ROCE | 50.38% | 46.70% | 50.33% |
| EPS | 9.88 | 4.88 | 4.76 |
| P/E PRE IPO | 12.47 | ||
| P/E Post IPO | 16.92 |
Company Financials (In ₹Crore)
| Period Ended | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Assets | 30.06 | 17.1 | 10.8 |
| Total Income | 26.29 | 23.8 | 20.41 |
| Profit After Tax | 7.34 | 3.66 | 3.25 |
| EBITDA | 11.41 | 5.83 | 4.17 |
| Net Worth | 14.78 | 7.44 | 3.78 |
| Reserves and Surplus | 7.28 | 6.44 | 2.78 |
| Total Borrowing | 9.09 | 3.92 | 3.59 |
COMPARISON WITH INDUSTRY PEERS
*Company does not have any peer group company for comparison with Industry Peer.
About Company
Incorporated: October 2017
Business Focus: Solvent recovery and trading, offering sustainable reuse solutions for industries using solvents.
Core Operations:
Solvent Recovery: Distillation & purification of spent solvents with capability to handle diverse mixtures and high batch variability.
Solvent Trading: Sourcing raw materials, quality assessment, and open-market sales.
Strengths: Sustainability-driven model, technical expertise in handling complex solvent recovery, and dual revenue streams (recovery + trading).
Strength
Good Reputation in the Pharmaceutical Sector – Trusted by pharma clients for reliable solvent recovery solutions, strengthening long-term business opportunities.
Modern Infrastructure – Advanced distillation and purification facilities enable efficient solvent recovery with higher yield and quality.
Diverse Market & Established Suppliers – Access to multiple industries and strong supplier relationships provide stability and reduce dependency on a single market.
Weakness
Looks like risky bat
Customer Concentration Risk – A significant share of revenue comes from a few customers; loss of any such customer could adversely impact business and financial performance.
Property Dependency Risk – Warehousing and registered office are on rented premises; non-renewal or termination of lease agreements may disrupt operations.
Supplier Concentration Risk – Dependence on a limited number of suppliers; loss of any key supplier may affect raw material availability and business continuity.
Snehaa Organics Latest Announcements
| Date | Subject | Attachment Text |
|---|
Snehaa Organics Financial Results
Snehaa Organics Lead Manager(s)
Snehaa Organics Address
Dulapally Adjacent to Ida Jeedimetla,
Quthbullapur, Rangareddi
Quthbullapur, Telangana, 500055
Phone: +91 8309404803
Email: info.snehaapharma@gmail.com
Website: https://snehaaorganics.com/